Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
US6894068B2 · kind B2 · utility
9Cited by
14References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2002 |
| Grant date | May 17, 2005 |
| Priority date | — |
| Expiry date | Sep 15, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the treatment of HIV infection. In particular, the present invention provides non-nucleoside inhibitors of reverse transcriptase (RT), as well as methods to treat HIV infection using these non-nucleoside inhibitors of RT. In preferred embodiments, the present invention provides a novel class of substituted benzimidazoles, effective in the inhibition of human immunodeficiency virus (HIV) RT.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.